Arturo Loaiza-Bonilla Md

Co-Founder, Massive Bio | Network Chief of Hematology and Oncology, SLUHN | WebMD Medscape Columnist | AI in Oncology | 40 under 40 in Cancer | OpenAI Forum | HealthTech | DrArturoAI | Investor | Board Advisor |

📍 Greater Philadelphia, United States🔄 Updated July 2026💼 4 investments📅 12 years investing🗓 Last invested Aug 2025𝕏 @upgrade_to_unlock
VC🌍 United StatesInvested this year
4
Total investments
1
Early stage
1
Mid stage
1
Late stage
12y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and Product Development Board
Aug 2025
HEARTio is a digital diagnostic startup that uses artificial intelligence to help physicians identify heart abnormalities.
Clinical Board Member
Sep 2018
For life sciences companies pursuing digital transformation, we offer the leading technology to rapidly develop, launch, and scale digital solutions. Our cloud-based platform is the trusted foundation for companion apps, algorithms, connected combination products, healthcare provider interfaces and other Software as a Medical Device (SaMD).   Our customers partner with BrightInsight to differentiate their therapies and harness unique real-world data to drive measurable value. With a track record of successful product launches that yield business and clinical ROI for top life sciences companies’ flagship brands in their largest markets, BrightInsight is the proven leader in this space.
Esophagogastric Cancer Task Force Investigator
Jun 2015
We are a multidisciplinary membership-based scientific organization that designs and conducts biomarker-driven cancer research involving adults who have or are at risk of developing cancer
Experience · 9 entries
All (9)
Investments (4)
Founder (1)
Board (2)
2025
Investor and Product Development Board
Aug 2025
HEARTio is a digital diagnostic startup that uses artificial intelligence to help physicians identify heart abnormalities.
2024
Associate Professor of Medicine
Dec 2024
Temple University School of Medicine (TUSM) has emerged as a leader in humanistic education for the next generation of physicians. Renowned for unsurpassed clinical training and exceptional researchers, the School of Medicine is internationally recognized, nationally honored and locally vital.
2023
Systemwide Chair of Medical Research
Apr 2023
Capital Health is the region’s leader in providing progressive, quality patient care with significant investments in our exceptional physicians, nurses and staff, as well as advanced technology. Comprised of two hospitals (our Regional Medical Center in Trenton and Capital Health Medical Center – Hopewell), our Hamilton outpatient facility, and various primary and specialty care practices across the region, Capital Health is a dynamic healthcare resource accredited by The Joint Commission and a three-time Magnet-designated health system for nursing excellence.
2018
Clinical Board Member
Sep 2018
For life sciences companies pursuing digital transformation, we offer the leading technology to rapidly develop, launch, and scale digital solutions. Our cloud-based platform is the trusted foundation for companion apps, algorithms, connected combination products, healthcare provider interfaces and other Software as a Medical Device (SaMD).   Our customers partner with BrightInsight to differentiate their therapies and harness unique real-world data to drive measurable value. With a track record of successful product launches that yield business and clinical ROI for top life sciences companies’ flagship brands in their largest markets, BrightInsight is the proven leader in this space.
2015
Esophagogastric Cancer Task Force Investigator
Jun 2015
We are a multidisciplinary membership-based scientific organization that designs and conducts biomarker-driven cancer research involving adults who have or are at risk of developing cancer
Show all 9 entries ↓
Investment activity
2014–2025 · 4 investments
20141201512018120251
Recent (last 2 years)Earlier